Clin Chest Med. 2024 Mar;45(1):105-118. doi: 10.1016/j.ccm.2023.08.006. Epub 2023 Sep 4.
ABSTRACT
Cardiac involvement is a major cause of morbidity and mortality in patients with sarcoidosis. It is important to distinguish between clinical manifest diseases from clinically silent diseases. Advanced cardiac imaging studies are crucial in the diagnostic pathway. In suspected isolated cardiac sarcoidosis, it's key to rule out alternative diagnoses. Therapeutic options can be divided into immunosuppressive agents, guideline-directed medical therapy, antiarrhythmic medications, device/ablation therapy, and heart transplantation.
PMID:38245360 | DOI:10.1016/j.ccm.2023.08.006